Artificial intelligence company Altris.Al announced it has signed an agreement with South Korean ophthalmic and optical medical equipment manufacturer Huvitz Co. aimed at the development of customized deep learning solutions for retinal diseases detection.
Terms of the deal were not disclosed.
Altris.AI’s OCT and fundus algorithms have been trained using anonymized OCT retinal scans as well as fundus images collected during more than 12 years, and are able to detect more than 50 retinal diseases and conditions, according to a company news release. Currently, Altris.AI’s solution is available in web and mobile version for structural retina analysis. The model shows the high level of performance with multi-disease classification accuracy more than 96%.
Altris.AI’s technology will complement Huvitz All-in-One 3D OCT and Fundus Camera device by adding new features for diagnostic support and automatic retinal diseases detection on OCT scans or Fundus images in combination or separately, which allows ophthalmologists and optometrists with basic knowledge to have higher level of performance as an experienced retinal imaging specialist in just couple of clicks.